BOLT - Bolt Biotherapeutics GAAP EPS of -$0.58 misses by $0.01 revenue of $2.1M beats by $0.87M November, 10 2022 05:13 PM Bolt Biotherapeutics Inc. Bolt Biotherapeutics press release ( NASDAQ: BOLT ): Q3 GAAP EPS of -$0.58 misses by $0.01 . Revenue of $2.1M (+162.5% Y/Y) beats by $0.87M . For further details see: Bolt Biotherapeutics GAAP EPS of -$0.58 misses by $0.01, revenue of $2.1M beats by $0.87M